Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,196.00
(
-1.18%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.55
(
-1.14%
)
Bitcoin
80,989.60
(
0.62%
)
News Focus
News Focus
Post# of 405212
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

sox040713

Send PM Follow Ignore
Followers 55
Posts 5540
Boards Moderated 0
Alias Born 11/04/2011

sox040713

Re: TimeWillTellAll post# 78610

Tuesday, 11/18/2014 12:43:14 AM

Tuesday, November 18, 2014 12:43:14 AM

Post# of 405212
I mentioned the following reason before. Daptomycin will go off patent in 2016. Since the earliest Brilacidin can be approved is 2016, B will not affect D in sales before then. If the trial was Phase 3 and B will be approved in 2015, Cubist's stock price will definitely be affected IMO.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote